**IF YOU HAVE PROBLEM ACESSING www.silislabs.com USE www.silislabs.co.in INSTEAD** ****Annual Deepawali Vacation from Thursday, November 4, 2021 till Monday November 8, 2021 (both dates inclusive)****

DCGI, INDIA

Dr. Venugopal G Somani

Dr. Venugopal G Somani is now new DCGI since July 2019.

Dr. V. G. Somani, M. Pharm, Ph. D in (Pharmaceutical Sciences) from Nagpur University, Nagpur, India, who has worked as a Joint Drugs Controller (India) in CDSCO (HQ), MoHFW, DGHS, Govt. of India and is heading the Divisions of Regulation of Medical Devices & In vitro Diagnostics, Stem cells & Blood Products, New Drugs (which are Subsequent & Fixed Dose Combination), He has also worked as JDC (I) heading the divisions of Biologicals, Clinical Trial, New Drugs, Cosmetics, Enforcements etc. for several years. He is primarily involved in dossier assessment, monitoring, and framing of proposals for amendments in Rules, policies, and guidelines.

Officiated as Drugs Controller General (India) on the additional charge (Central Government of India) from 3rd Nov 2011 to 2nd Feb 2012 and also worked as 'Deputy Drugs Controller (I), Assistant Drugs Controller (I) and Drugs Inspector at CDSCO in various zonal offices like West Zone Mumbai, Ahmadabad, East Zone Kolkata, HQ New Delhi while conducting and monitoring GMP, GCP, and GLP inspection.

He has been actively involved in the National and International forum for policy making, training, selections, providing expert opinion for better regulatory processes.

Copyright © 2021 Silis Labs Pvt. Ltd.                                                 Developed & Maintained By iSummation Technologies